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“Probiotics and prebiotics have
become part of the lexicon of food
technologists,” writes Gerald W.
Tannock, editor of the provocative
new book, Probiotics and Prebiotics:
Where Are We Going? Probiotics
were defined by Fuller in 1989, as
“live microbial feed supplements that
beneficially affect the host animal by
improving its intestinal microbial bal-
ance.” The concept of probiotics is
not new, however. Approximately 100
years ago, Elie Metchnikoff, the
father of immunology, investigated
intestinal microbes as causative
agents in aging, a process he called
“autointoxication.” He believed that
lactic acid–producing bacteria (such
as those found in yogurt) would sup-
press the growth of more proteolytic,
autointoxicating bacteria. 
Prebiotics have been defined as
“nondigestible food ingredients (usu-
ally carbohydrates) that beneficially
affect the host by selectively stimulat-
ing the growth and/or activity of one
or a limited number of bacteria in the
colon.” Potential prebiotics have
included bifidobacteria, indigenous
microbes epidemiologically associat-
ed with long life and other healthful
conditions.
The concept of probiotics has been
developing over recent decades, and
the use of prebiotics extends this idea.
Although the ideas are intriguing, the
central theories to be tested and the
tools necessary to test them have been
lacking. This book contributes sub-
stantially to addressing these difficul-
ties. The opening chapter, by
Tannock, is rich in ideas and sets the
appropriate tone for the rest of the
book. The other nine chapters, by 20
other authors from seven countries,
address both hypotheses and specifics
in state-of-the-art reviews.
The central issue in this field is the
following: how can the metabolic
activities of the bacterial population
in the colon be manipulated to pro-
mote health? Rigorous scientific
exploration of this question has been
limited by two factors: the colonic
biota (flora) is vast and also largely
undefined. In consequence, many
studies, fueled by commercial self-
interest, have lacked the stringency
necessary for true scientific advance-
ment. Accordingly, a substantial por-
tion of this book discusses the meth-
ods, current or being developed, that
will help address these deficiencies.
Improved methods hold the promise
of better defining which bacteria are
present, distinguishing how much the
biota varies from person to person,
and measuring how well persons
respond to probiotics and prebiotics.
Another important issue is explor-
ing the relationship of the microbial
biota and the host, especially the
healthy host; such microecologic
studies are critical to understanding
potential microbial contributions to
disease. Again, development of stan-
dard methods would permit these
assessments; without extensive cata-
loging, we cannot establish the base-
line.
A third and related issue is defin-
ing conditions that might be amelio-
rated by probiotic or prebiotic thera-
pies. The authors provide a long list of
such diseases, including colon cancer,
inflammatory bowel disease, and
some less obvious candidates such as
osteoporosis and atopic diseases (for
example, asthma). Some researchers
have hypothesized that these latter
diseases result from a childhood
deprived of specific pathogens, the
“hygiene hypothesis.” Use of probi-
otics and prebiotics has been
advanced as one solution to that prob-
lem.
In summary, Probiotics and
Prebiotics is an important book, from
which I have learned much. One defi-
ciency, however, is the book’s
remarkable absence of discussion
about the role of these agents in the
selection of particular bacterial popu-
lations. The focus of the book, and of
the field, is largely on metabolism, but
any of the anticipated therapies, espe-
cially prebiotics, will select for partic-
ular bacterial species or phenotypes.
A greater focus on the biology of
selection in this milieu would have
been helpful. Nevertheless, this limi-
tation does not substantially reduce
the great utility of this volume to
those interested in ecology, microbiol-
ogy, medicine, or nutrition. This book
explores a field that is out of the main-
stream of human biology and medi-
cine but deserves to be more central.
For a field often marked by hyperbole
because of commercially based con-
flicts of interest, this book is appropri-
ately subdued and scientifically bal-
anced. The editor and authors should
be credited for their scholarly
approach.
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